Recce’s Phase 2 trial for skin infections hits midway recruitment milestone
Recce sees progression of Phase 2 study assessing efficacy of RECCE® 327 (R327G) topical gel against acute bacterial skin and...
Recce sees progression of Phase 2 study assessing efficacy of RECCE® 327 (R327G) topical gel against acute bacterial skin and...
Dr. Jabi Shriki, a distinguished radiologist known for his expertise in diagnostic radiology, delves into the recent implementation of a...